% | $
Quotes you view appear here for quick access.

Cyclacel Pharmaceuticals, Inc. Message Board

  • bella_bionda_16 bella_bionda_16 Sep 10, 2013 6:40 AM Flag

    CYCC initiated at Buy by Janney Montgomery Scott, PT $10


    CYCC initiated at Buy by Janney Montgomery Scott, PT $10

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • $10 is too low. After interim results, partnership, and key developments in RMDS development, I see us at a market cap of over 500M (~$30/share) in 12 months. A surprise Accelerated Approval in RMDS could put us in the Billions. DO NOT SELL THIS STOCK.

      Sentiment: Strong Buy

      • 1 Reply to lifetolive7
      • from May 16th dilution:
        Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share.
        and if you wonder why she says $10:
        This offering is expected to close on May 21, 2013, subject to customary closing conditions.

        JMP Securities LLC is acting as the sole book-running manager and Janney Montgomery Scott LLC is acting as co-manager for this offering.
        I'm thinking of buying and doing my DD. Getting out of ASTX after 4 years since the buyout. need to do something with the money. is it really worth $10?

0.65+0.01(+1.56%)Jul 27 3:53 PMEDT